To read our full disclaimer, click here.
Q3 results season is almost over, and it has left me with more healthcare microcaps worth a closer look than I can write up at once. So here are ten that have gone onto my watchlist, with what caught my eye in the numbers and what I want to see before each gets a full write-up.
The Research Portal now tracks 19 active ideas. With today’s ten, the watchlist grows from 4 names to 14.
What’s inside:
Idea #1: A profitable medical device microcap growing fast, with the shares down sharply from their high
Idea #2: A binary FDA decision due before the end of this month, with a commercial partner already signed
Idea #3: A newly launched drug with sales compounding quarter on quarter and no debt
Idea #4: A turnaround sitting on a large cash pile, plus a royalty deal with an industry giant
Idea #5: A founder-led healthcare software business with sticky recurring revenue, hit by a regulatory change
Idea #6: A razor-and-blade home infusion business that has just turned profitable
Idea #7: A healthcare services company whose growth has accelerated every quarter this year
Idea #8: A cash-rich antiviral developer one trial result away from filing
Idea #9: A picks-and-shovels play on gene therapy for the brain
Idea #10: An animal health microcap at an earnings inflection
Here are the ideas…

